HU906360D0 - Process for producing quinoline derivatives and pharmaceutical preparatives containing such compounds - Google Patents
Process for producing quinoline derivatives and pharmaceutical preparatives containing such compoundsInfo
- Publication number
- HU906360D0 HU906360D0 HU906360A HU636090A HU906360D0 HU 906360 D0 HU906360 D0 HU 906360D0 HU 906360 A HU906360 A HU 906360A HU 636090 A HU636090 A HU 636090A HU 906360 D0 HU906360 D0 HU 906360D0
- Authority
- HU
- Hungary
- Prior art keywords
- compounds
- quinoline derivatives
- chem
- preparatives containing
- producing quinoline
- Prior art date
Links
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 title abstract 2
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 102000001494 Sterol O-Acyltransferase Human genes 0.000 abstract 1
- 108010054082 Sterol O-acyltransferase Proteins 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Detergent Compositions (AREA)
- Holo Graphy (AREA)
- Measurement Of Radiation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP26278289 | 1989-10-06 | ||
| JP32229089 | 1989-12-11 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HU906360D0 true HU906360D0 (en) | 1991-04-29 |
| HUT55364A HUT55364A (en) | 1991-05-28 |
Family
ID=26545706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU906360A HUT55364A (en) | 1989-10-06 | 1990-10-05 | Process for producing quinoline derivatives and pharmaceutical compositions comprising such compounds as active ingredient |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5223513A (hu) |
| EP (1) | EP0421456B1 (hu) |
| KR (1) | KR910007883A (hu) |
| CN (1) | CN1050715A (hu) |
| AT (1) | ATE116301T1 (hu) |
| AU (1) | AU629048B2 (hu) |
| CA (1) | CA2026890C (hu) |
| DE (1) | DE69015541T2 (hu) |
| FI (1) | FI904915A7 (hu) |
| HU (1) | HUT55364A (hu) |
| IE (1) | IE903454A1 (hu) |
| IL (1) | IL95839A (hu) |
| NO (1) | NO904300L (hu) |
| NZ (1) | NZ235582A (hu) |
| PT (1) | PT95515A (hu) |
| RU (1) | RU2001910C1 (hu) |
| TW (1) | TW205037B (hu) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03181465A (ja) * | 1989-12-11 | 1991-08-07 | Takeda Chem Ind Ltd | キノリン誘導体 |
| FI934710L (fi) * | 1991-04-26 | 1993-10-25 | Pfizer | 4-aryl-3-(heteroarylureido)kinolinderivat |
| WO1993015058A1 (en) * | 1992-01-23 | 1993-08-05 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
| TW241258B (hu) * | 1992-04-15 | 1995-02-21 | Takeda Pharm Industry Co Ltd | |
| CA2134359C (en) * | 1992-05-28 | 1997-07-01 | Ernest S. Hamanaka | New n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat) |
| ATE161530T1 (de) * | 1992-09-04 | 1998-01-15 | Takeda Chemical Industries Ltd | Kondensierte heterozyklische verbindungen, deren herstellung und verwendung |
| US5565472A (en) * | 1992-12-21 | 1996-10-15 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
| NZ264063A (en) * | 1993-08-13 | 1995-11-27 | Nihon Nohyaku Co Ltd | N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions |
| TW263498B (hu) * | 1993-11-10 | 1995-11-21 | Takeda Pharm Industry Co Ltd | |
| US6133326A (en) | 1994-08-31 | 2000-10-17 | Pfizer Inc | Compositions and methods for decreasing sebum production |
| US5843957A (en) * | 1995-05-19 | 1998-12-01 | Sumitomo Pharmaceuticals Company, Ltd. | Naphthyridine derivatives |
| CA2301549A1 (en) * | 1997-08-28 | 1999-03-04 | Piyasena Hewawasam | 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators |
| AU2547399A (en) | 1998-02-25 | 1999-09-15 | Sumitomo Pharmaceuticals Company, Limited | Pyridone derivatives and process for producing the same |
| US6452008B2 (en) | 1998-02-25 | 2002-09-17 | Sumitomo Pharmaceuticals Company, Limited | Pyridone derivatives and process for preparing the same |
| ATE354569T1 (de) * | 1998-12-04 | 2007-03-15 | Bristol Myers Squibb Co | 3-substituierte-4-arylchinolin-2-on derivate als kaliumkanal- modulatoren |
| DZ3288A1 (en) | 2000-02-02 | 2001-08-09 | Warner Lambert Co | Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders |
| US6852862B2 (en) * | 2001-03-02 | 2005-02-08 | Sumika Fine Chemicals Co., Ltd. | Process for producing quinoline-3-carboxylic acid compound |
| CZ20032898A3 (cs) * | 2001-04-30 | 2004-07-14 | Pfizer Products Inc. | Způsob výroby inhibitorů CETP |
| JP4794445B2 (ja) * | 2003-09-23 | 2011-10-19 | メルク・シャープ・エンド・ドーム・コーポレイション | キノリンカリウムチャネル阻害剤 |
| AU2012331289B2 (en) | 2011-11-04 | 2017-07-13 | F. Hoffmann-La Roche Ag | New aryl-quinoline derivatives |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1216878B (de) * | 1963-04-02 | 1966-05-18 | Cassella Farbwerke Mainkur Ag | Verfahren zur Herstellung von coronargefaesserweiternden Derivaten des 7-Hydroxy-2-oxo-1, 2-dihydrochinolins |
| NO133758C (hu) * | 1970-04-04 | 1976-06-23 | Takeda Chemical Industries Ltd | |
| JPS555502B1 (hu) * | 1971-07-31 | 1980-02-07 | ||
| US4530931A (en) * | 1983-01-03 | 1985-07-23 | Usv Pharmaceutical Corp. | 8-Quinoline carbanilates for the inhibition of lipolysis |
| DE3586445T2 (de) * | 1984-06-26 | 1993-01-14 | Merck & Co Inc | Kondensierte benzo-laktam-verbindungen und deren pharmazeutische zusammensetzungen. |
| IE892088L (en) * | 1988-07-12 | 1990-01-12 | William Henry Deryk Morris | Quinoline derivatives, their production and use |
-
1990
- 1990-09-20 TW TW079107912A patent/TW205037B/zh active
- 1990-09-25 US US07/587,795 patent/US5223513A/en not_active Expired - Fee Related
- 1990-09-25 IE IE345490A patent/IE903454A1/en unknown
- 1990-09-28 IL IL9583990A patent/IL95839A/en not_active IP Right Cessation
- 1990-09-28 AU AU63707/90A patent/AU629048B2/en not_active Ceased
- 1990-10-03 NO NO90904300A patent/NO904300L/no unknown
- 1990-10-04 PT PT95515A patent/PT95515A/pt not_active Application Discontinuation
- 1990-10-04 CA CA002026890A patent/CA2026890C/en not_active Expired - Fee Related
- 1990-10-05 CN CN90108222A patent/CN1050715A/zh active Pending
- 1990-10-05 NZ NZ235582A patent/NZ235582A/en unknown
- 1990-10-05 EP EP90119128A patent/EP0421456B1/en not_active Expired - Lifetime
- 1990-10-05 FI FI904915A patent/FI904915A7/fi not_active Application Discontinuation
- 1990-10-05 RU SU904831426A patent/RU2001910C1/ru active
- 1990-10-05 DE DE69015541T patent/DE69015541T2/de not_active Expired - Fee Related
- 1990-10-05 HU HU906360A patent/HUT55364A/hu unknown
- 1990-10-05 AT AT90119128T patent/ATE116301T1/de not_active IP Right Cessation
- 1990-10-06 KR KR1019900015908A patent/KR910007883A/ko not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR910007883A (ko) | 1991-05-30 |
| NO904300D0 (no) | 1990-10-03 |
| PT95515A (pt) | 1991-08-14 |
| AU6370790A (en) | 1991-04-11 |
| IL95839A (en) | 1995-03-15 |
| US5223513A (en) | 1993-06-29 |
| JPH03223254A (ja) | 1991-10-02 |
| HUT55364A (en) | 1991-05-28 |
| FI904915A0 (fi) | 1990-10-05 |
| CN1050715A (zh) | 1991-04-17 |
| EP0421456A2 (en) | 1991-04-10 |
| IE903454A1 (en) | 1991-04-10 |
| IL95839A0 (en) | 1991-06-30 |
| DE69015541T2 (de) | 1995-06-01 |
| EP0421456A3 (en) | 1991-05-29 |
| NO904300L (no) | 1991-04-08 |
| CA2026890C (en) | 2001-09-18 |
| NZ235582A (en) | 1992-03-26 |
| FI904915A7 (fi) | 1991-04-07 |
| ATE116301T1 (de) | 1995-01-15 |
| AU629048B2 (en) | 1992-09-24 |
| EP0421456B1 (en) | 1994-12-28 |
| TW205037B (hu) | 1993-05-01 |
| DE69015541D1 (de) | 1995-02-09 |
| RU2001910C1 (ru) | 1993-10-30 |
| CA2026890A1 (en) | 1991-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU906360D0 (en) | Process for producing quinoline derivatives and pharmaceutical preparatives containing such compounds | |
| HUT52059A (en) | Process for producing pharmaceutical compositions and new quinoline derivatives as a group of active components | |
| AU8347991A (en) | 1-methylcarbapenem derivatives and process for preparation thereof | |
| HUT41713A (en) | Process for production of //arol-cyclobutyl/ alkyl/-amins and medical preparatives containing thereof | |
| HUT67283A (en) | Method for producing n-containing fused heterocyclic ketone derivatives and medical preparatives containing them | |
| IL86462A (en) | Alkanesulfonanilide derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same | |
| AU598229B2 (en) | Novel indenothiazole derivatives and process for their preparation | |
| AU643759B2 (en) | Urea derivatives and salts thereof, pharmaceutical compositions containing the same, and methods for producing the same | |
| ES8604912A1 (es) | Procedimiento de preparacion de nuevos derivados de (arilpi-peraziniletilaminoetoxi)-4 fenol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DFD9 | Temporary protection cancelled due to non-payment of fee |